| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/19/2001 | US6248538 Kit for detecting antibodies against preferential bacteria; for the detection of lyme disease |
| 06/19/2001 | US6248536 Bacillus thuringiensis CryET33 and CryET34 compositions and uses thereof |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248531 Trans-platinum compound, and diagnostic kit |
| 06/19/2001 | US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein |
| 06/19/2001 | US6248527 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 06/19/2001 | US6248523 Mammalian tumor susceptibility genes and their uses |
| 06/19/2001 | US6248521 Dew point in chamber is maintained to prevent evaporation of solution at discrete points of solid phase substrate where reactions are taking place |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/19/2001 | US6248515 Methods for the early detection of HIV infection |
| 06/19/2001 | US6248514 Methods for measuring viral infectivity |
| 06/19/2001 | US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes |
| 06/19/2001 | US6248353 Reconstitution of purified membrane proteins into preformed liposomes |
| 06/19/2001 | US6248327 Using antibody |
| 06/19/2001 | US6248229 Electrode bound to a transition metal complex bearing ligands of analyte, i.e., a drug or protein, which complex binds to a binding partner, i.e., an antibody, to form a detectable sterically hindered complex; competitive binding assay |
| 06/19/2001 | US6248078 Volatile biomarkers for analysis of hepatic disorders |
| 06/19/2001 | US6248067 Analyte sensor and holter-type monitor system and method of using the same |
| 06/19/2001 | US6248063 Computer assisted methods for diagnosing diseases |
| 06/19/2001 | US6248057 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 06/19/2001 | US6247370 Two dimensional stress relaxation testing device |
| 06/19/2001 | CA2021116C Topical compositions containing live yeast cell derivative and other topically active medicinal ingredients |
| 06/19/2001 | CA2011722C Reagents for the determination of drugs |
| 06/19/2001 | CA2004068C Hair analysis method |
| 06/19/2001 | CA2003307C Streptolysin o antigen derivative, its production and uses |
| 06/19/2001 | CA1341259C Particle vector useful as a carrier of biologically active molecules, and a fabrication method |
| 06/15/2001 | CA2328567A1 Logistic regression trees for drug analysis |
| 06/14/2001 | WO2001042795A2 Transferrin assay |
| 06/14/2001 | WO2001042794A2 Method for identifying inhibitors of cytokinesis |
| 06/14/2001 | WO2001042793A2 Diagnostic assay for stroke |
| 06/14/2001 | WO2001042792A2 Diagnosis of cervical cancer using marker proteins |
| 06/14/2001 | WO2001042791A1 Eia for monitoring legionella pneumophila presence in water samples |
| 06/14/2001 | WO2001042790A2 Agents and method for diagnosing lyme disease and borreliosis vaccine |
| 06/14/2001 | WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
| 06/14/2001 | WO2001042788A2 Analyte assay device with preabsorbing zone |
| 06/14/2001 | WO2001042787A2 Immunoassay for neonicotinyl insecticides |
| 06/14/2001 | WO2001042786A2 System for cell based screening : cell spreading |
| 06/14/2001 | WO2001042784A2 Methods for screening compounds active on neurons |
| 06/14/2001 | WO2001042783A1 Process for determining the degeneration level of keratinic fibers (hair) |
| 06/14/2001 | WO2001042782A1 Characterization of hybridized polymer molecules based on monomer-interface interactions |
| 06/14/2001 | WO2001042781A2 Supracolonic aerodigestive neoplasm detection |
| 06/14/2001 | WO2001042773A1 Method and arrangement for determining the profile of a coating layer |
| 06/14/2001 | WO2001042768A1 Surface plasmon resonance |
| 06/14/2001 | WO2001042760A1 Powder sampling method and apparatus |
| 06/14/2001 | WO2001042757A2 Sperm quality assay |
| 06/14/2001 | WO2001042737A1 Tissue sensor |
| 06/14/2001 | WO2001042508A2 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 06/14/2001 | WO2001042503A2 Apparatus and methods for drug screening based on nucleic acid analysis |
| 06/14/2001 | WO2001042499A1 Method of testing remedy or preventive for hyperlipemia |
| 06/14/2001 | WO2001042497A2 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 06/14/2001 | WO2001042495A2 Products comprising a support whereon are fixed nucleic acids and their use as dna chip |
| 06/14/2001 | WO2001042494A2 Test system for detecting analytes, a method for the production thereof and its use |
| 06/14/2001 | WO2001042490A2 Novel alizarin-based chromogenic substrates |
| 06/14/2001 | WO2001042489A1 Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes |
| 06/14/2001 | WO2001042488A2 Plasminogen activator assay involving an elastase inhibitor |
| 06/14/2001 | WO2001042487A2 Device for extraction of nucleic acids |
| 06/14/2001 | WO2001042473A2 Device and method for accelerated hydration of dry chemical sensors |
| 06/14/2001 | WO2001042467A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/14/2001 | WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus |
| 06/14/2001 | WO2001042453A1 Structural coordinate and nmr chemical shift of protein and utilization thereof |
| 06/14/2001 | WO2001042450A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 06/14/2001 | WO2001042439A1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase |
| 06/14/2001 | WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 06/14/2001 | WO2001042429A1 Infection of eukaryotic cells with viruses in vitro |
| 06/14/2001 | WO2001042307A1 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION |
| 06/14/2001 | WO2001042299A2 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001041930A1 A device for analytical determinations |
| 06/14/2001 | WO2001041929A1 Device for binding a target molecule |
| 06/14/2001 | WO2001041917A1 Heat-relaxable substrates and arrays |
| 06/14/2001 | WO2001041815A2 Metastasis genes and uses thereof |
| 06/14/2001 | WO2001041813A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041784A1 Methods and compositions for use in the treatment of filovirus mediated disease conditions |
| 06/14/2001 | WO2001041767A1 USE OF α1AR SUBTYPE-SELECTIVE DRUGS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION |
| 06/14/2001 | WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone |
| 06/14/2001 | WO2001041740A2 Reconstitution of purified membrane proteins into preformed liposomes |
| 06/14/2001 | WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | WO2001041644A1 Constant speed blood sample collection system |
| 06/14/2001 | WO2001041643A1 Body fluid measuring apparatus with lancet and lancet holder used for the measuring apparatus |
| 06/14/2001 | WO2001041555A1 Moisture detection |
| 06/14/2001 | WO2001041543A2 Pesticidal activity of functionalized alkenes |
| 06/14/2001 | WO2001016860A3 Artificial intelligence system for genetic analysis |
| 06/14/2001 | WO2001014878A9 Method and kit for detecting betalactam-containing compounds |
| 06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | WO2000072020A8 Microscale diffusion immunoassay |
| 06/14/2001 | WO2000071747A3 Detection system for separating constituents of a sample and production and use of the same |
| 06/14/2001 | WO2000070096A3 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| 06/14/2001 | WO2000041623A9 A breath test for the detection of various diseases |
| 06/14/2001 | WO2000035950A9 Reagents and methods useful for detecting diseases of the breast |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | US20010003777 Individualized anti-cancer antibodies |
| 06/14/2001 | US20010003649 Nucleic acid-immobilized substrate |